Search Results - "Brelière, Jean Claude"
-
1
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Published in FEBS letters (22-08-1994)“…SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor. This compound displays nanomolar affinity for the central…”
Get full text
Journal Article -
2
Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist
Published in Life sciences (1973) (1995)“…SR141716A is a selective, potent and orally active antagonist of the brain cannabinoid receptor with a long duration of action. This compound shows high…”
Get more information
Journal Article -
3
In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist
Published in European journal of pharmacology (21-12-1993)“…(S)1-(2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl)pip eridin-3- yl]ethyl)-4-phenyl-1-azoniabicyclo[2.2.2]octane chloride (SR140333) is a new…”
Get more information
Journal Article -
4
Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
Published in Psychopharmacologia (20-05-1999)“…Rationale: A cannabinoid hypothesis of schi- zophrenia has been proposed according to which cognitive dysfunction could be associated with dysregulation of an…”
Get full text
Journal Article -
5
Characterization and distribution of binding sites for [ 3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain
Published in Life sciences (1973) (1996)“…SR 141716A belongs to a new class of compounds (diarylpyrazole) that inhibits brain carmabinoid receptors (CB1) in vitro and in vivo . The present study showed…”
Get full text
Journal Article -
6
Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists
Published in FEBS letters (16-12-1996)“…Substance P (SP) has been reported to induce inflammatory cytokine production in human neuroglial cells and peripheral lymphoid cells as well. In order to…”
Get full text
Journal Article -
7
A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists
Published in Journal of medicinal chemistry (01-10-1993)“…Starting from the structure of the novel nonpeptide AT1 receptor antagonist DuP 753 (losartan), a new series of potent antagonists was designed. In these…”
Get full text
Journal Article -
8
Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses
Published in Journal of neuroimmunology (01-07-1994)“…In our preceding paper, we demonstrated that both human and rat lymphocytes possess saturable high-affinity binding sites for the new sigma ligand SR 31747…”
Get more information
Journal Article -
9
Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747
Published in Journal of neuroimmunology (01-07-1994)“…The interactions of a new compound SR 31747 with sigma sites were examined in rat spleen membranes and in human peripheral blood leukocytes (PBL). Nanomolar…”
Get more information
Journal Article -
10
Turning behavior induced in mice by a neurokinin A receptor agonist: stereoselective blockade by SR 48968, a non-peptide receptor antagonist
Published in Neuroscience letters (04-01-1993)“…The intrastriatal injection of [Nle10]-NKA(4-10), a neurokinin A agonist, (0.05-5 ng/mouse) elicited vigorous contralateral rotations. This behavior was…”
Get more information
Journal Article -
11
The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception
Published in European journal of pharmacology (11-06-1993)“…Extracellular recordings were made in the thalamic posterior nuclear group of anesthetized rats to study the effects of SR48968, a non-peptide NK2 receptor…”
Get more information
Journal Article -
12
Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain
Published in Life sciences (1973) (1994)“…SR 46349B belongs to a new class of compounds (propenone oxime ether derivative) that inhibit 5-hydroxytryptamine (HT)2 receptors in vitro and in vivo. (3H) SR…”
Get more information
Journal Article -
13
SR 48968, a neurokinin A (NK2) receptor antagonist
Published in Regulatory peptides (02-07-1993)Get more information
Journal Article -
14
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
Published in The Journal of pharmacology and experimental therapeutics (01-02-1998)“…Based on both binding and functional data, this study introduces SR 144528 as the first, highly potent, selective and orally active antagonist for the CB2…”
Get more information
Journal Article -
15
Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells
Published in Biochemical pharmacology (15-11-1985)“…Articular chondrocytes and synovial cells were stimulated to produce collagenase, neutral casein and proteoglycan-degrading proteinases by conditioned medium…”
Get more information
Journal Article -
16
Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activities
Published in Canadian journal of physiology and pharmacology (01-06-1997)“…In vitro tachykinin-induced contractions of guinea pig ileum longitudinal smooth muscle were investigated under isometric conditions by using selective…”
Get more information
Journal Article -
17
Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors
Published in Proceedings of the National Academy of Sciences - PNAS (01-07-1993)“…The molecular mechanism of action for two chemically distinct and highly selective, nonpeptide antagonists, CP-96,345 and SR-48,968, was studied by development…”
Get full text
Journal Article -
18
Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor
Published in Molecular pharmacology (01-03-1994)“…The molecular mechanism of action of three chemically distinct nonpeptide antagonists, SR 140,333, FK 888, and RP 67,580, was compared with that of the…”
Get more information
Journal Article -
19
Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors
Published in The American review of respiratory disease (01-11-1992)“…Tachykinins produce concentration-dependent contraction of the human isolated bronchus by stimulation of receptors that belong to the NK2 type. The aim of this…”
Get more information
Journal Article -
20
Two Nonpeptide Tachykinin Antagonists Act Through Epitopes on Corresponding Segments of the NK1and NK2Receptors
Published in Proceedings of the National Academy of Sciences - PNAS (01-07-1993)“…The molecular mechanism of action for two chemically distinct and highly selective, nonpeptide antagonists, CP-96,345 and SR-48,968, was studied by development…”
Get full text
Journal Article